000			04088nam a22003855i 4500
999			_c76168 _d76168
001			76168
003			ES-MaUEC
005			20240109113512.0
007			cr nn 008mamaa
008			100301s2006 xxu| s |||| 0|eng d
020			_a9781592599707
024	7		_a10.1007/978-1-59259-970-7 _2doi
040			_bspa _dES-MaUEC
050		4	_aQR189 _b2006 EB
082	0	4	_a616.079
100	1		_aHackett, Charles J. _eeditor. _985084 _0Local
245	1	0	_aVaccine Adjuvants : _bImmunological and Clinical Principles _cedited by Charles J. Hackett, Donald A. Harn.
260			_aTotowa, NJ _bHumana Press _c2006.
300			_bonline resource.
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aInfectious Disease
505	0		_aMicrobial Pathogenesis and the Discovery of Toll-Like Receptor Function -- Dendritic Cells -- Achieving Transcriptional Specificity in NF-?B-Dependent Inflammatory Gene Expression -- Adjuvants and the Initiation of T-Cell Responses -- Mechanism for Recognition of CpG DNA -- CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines -- Modified Bacterial Toxins -- Glycosylphosphatidylinositol Anchors As Natural Immunological Adjuvants Derived From Protozoan Parasites -- The Immunomodulatory Glycan LNFPIII/Lewis X Functions As a Potent Adjuvant for Protein Antigens -- Immune and Antiviral Effects of the Synthetic Immunomodulator Murabutide -- Effects of QS-21 on Innate and Adaptive Immune Responses -- Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators -- Microparticles and DNA Vaccines.
520			_aRecent major advances in our understanding of basic immunology have led to the development of powerful new adjuvants-substances that can stimulate the innate immune system and significantly improve the effectiveness of antigen-based vaccines. In Vaccine Adjuvants: Immunological and Clinical Principles, highly respected clinical immunologists and vaccine researchers detail the major research areas in this new era of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses. Among the highlights are an explanation of innate immune signaling-including Toll-like receptors-in vaccination, and a preview of emerging technologies in adjuvant research, such as microparticles and novel lipid and carbohydrate adjuvants. Authoritative and eminently practical, Vaccine Adjuvants: Immunological and Clinical Principles moves from the basic principles of the innate immune system, through the characteristics of specific adjuvants, to detailed methods for developing the safer and more effective adjuvants that will trigger these powerful immune responses, and finally to the combinations of immune responses needed for successful vaccination.
650		7	_2embne _9140409 _aVacunas
700	1		_aHarn, Donald A. _eeditor. _985085 _0Local
710	2		_aSpringerLink (Online service) _0Local _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-59259-970-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12817867 _b10-10-17 _c01-10-14
942			_2lcc _cLE
945			_aQR187.3 H335 2006 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1154708x _z06-04-17
988			_aEBSPRINGER
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxu _h0